Comparison of Human Papillomavirus detection and genotyping with four different prime sets by PCR-sequencing

Biomedical and Environmental Sciences

Volumn 26, Issue 1, 2013, Pages 40-47

  Cai, Yu Pin ^a,c   Yang, Yi ^b   Zhu, Bao Li ^a   Li, Yuan ^b   Xia, Xiao Yu ^b   Zhang, Rui Fen ^a   Xiang, Yang ^b  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Cervical cancer; DNA sequencing; Human Papillomavirus; Polymerase chain reaction

Indexed keywords

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; VIROLOGY;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; YOUNG ADULT;

MLCS; MLOWN;

EID: 84874423671     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/0895-3988.2013.01.005     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet], Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.larc.fr
2. Yang L, Parkin DM, Li L, et al. Time trends in cancer mortality in China: 1987-1999. Int J Cancer, 2003;106, 771-83.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999;189, 12-9.
4. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 2002;55, 244-65.
5. de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology, 2004;324, 17-27.
6. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 2003;348, 518-27.
7. Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer, 2004;111, 278-85.
8. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 2007;121, 621-32.
9. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst, 2001;93, 293-9.
10. de Roda Husman AM, Walboomers JM, Vandenbrule AJ, et al. The Use of General Primers Gp5 and Gp6 Elongated at Their 3' Ends with Adjacent Highly Conserved Sequences Improves Human Papillomavirus Detection by Per. J Gen Virol, 1995;76, 1057-62.
11. Manos MM, Ting Y, Wright DK, et al. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells, 1989;7, 209-14.
12. Villa LL, Denny L. Methods for detection of HPV infection and its clinical utility. Int J Gynecol Obstet, 2006;94, S71-S80.
13. Gravitt PE, Peyton CL, Alessi TO, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol, 2000;38, 357-61.
14. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis, 1994;170, 1077-85.
15. Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5+/GP6 (+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol, 1997;35, 791-5.
16. Gravitt PE, Peyton CL, Apple RJ, et al. Genotyping of 27 human papillomavirus types by using LI consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol, 1998;36, 3020-7.
17. van den Brule AJ, Pol R, Fransen-Daalmeljer N, et al. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol, 2002;40, 779-87.
18. Soderlund-Strand A, Dillner J, Carlson J. High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry. Clin Chem, 2008;54, 86-92.
19. Patel DA, Shih YJ, Newton DW, et al. Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirus. J Virol Methods, 2009;160, 78-84.
20. Feoli-Fonseca JC, Oligny LL, Brochu P, et al. Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol, 2001;63, 284-92.
21. Asato T, Maehama T, Nagai Y, et al. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis, 2004;189, 1829-32.
22. Fontaine V, Mascaux C, Weyn C, et al. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J Clin Microbiol, 2007;45, 928-34.
23. Milutin Gasperov N, Sabol I, Matovina M, et al. Detection and typing of human papillomaviruses combining different methods: polymerase chain reaction, restriction fragment length polymorphism, line probe assay and sequencing. Pathol Oncol Res, 2008;14, 355-63.
24. Vernon SD, Linger ER, and Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol, 2002;38, 651-5.
25. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA, 2002;287, 2114-9.
26. Sotlar K, Diemer D, Dethleffs A, et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol, 2004;42, 3176-84.
27. Bao YP, Li N, Smith JS, et al. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis. Int J STD AIDS, 2008;19, 106-11.
28. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 2005;366, 991-8.
29. Zhao R, Zhang WY, Wu MH, et al. Human papillomavirus infection in Beijing, People's Republic of China: a population-based study. Br J Cancer, 2009;101, 1635-40.
30. Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol, 1997;35, 1304-10.
31. Klug SJ, Molijn A, Schopp B, et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol, 2008;80, 1264-74.
32. Kado S, Kawamata Y, Shino Y, et al. Detection of human papillomaviruses in cervical neoplasias using multiple sets of generic polymerase chain reaction primers. Gynecol Oncol, 2001;81, 47-52.
33. Chan PK, Cheung TH, Tam AO, et al. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer, 2006;118, 243-5.
34. Sun ZR, Ji YH, Zhou WQ, et al. Characteristics of HPV prevalence among women in Liaoning province, China. Int J Gynaecol Obstet, 2010;109, 105-9.
35. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis, 2005;191, 1796-807.
36. Terai M, Burk RD. Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: candHPV89, candHPV90, and candHPV91. J Infect Dis, 2002;185, 1794-7.
37. Speich N, Schmitt C, Bollmann R, et al. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol, 2004;53, 125-8.
38. Castle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol, 2002;68, 417-23.
39. Coutlee F, Gravitt P, Kornegay J, et al. Use of PGMY primers in LI consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol, 2002;40, 902-7.
40. Dai M, Bao YP, Li N, et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer, 2006;95, 96-101.
41. Huang S, Afonina I, Miller BA, et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer, 1997;70, 408-11.
42. Clifford G, Franceschi S, Diaz M, et al. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 2006;24 Suppl 3, S3/26-34.
43. Castle PE, Schiffman M, Burk RD, et al. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev, 2002;11, 1394-9.
44. Poljak M, Marin IJ, Seme K, et al. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol, 2002;25 Suppl 3, S89-97.
45. Seme K, Fujs K, Kocjan BJ, et al. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping. J Virol Methods, 2006;134, 252-6.
46. Castle PE, Gravitt PE, Solomon D, et al. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol, 2008;46, 109-17.
47. Sargent A, Bailey A, Almonte M, et al. Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer, 2008;98, 1704-9.
48. Pannier-Stockman C, Segard C, Bennamar S, et al. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. J Clin Virol, 2008;42, 353-60.